Subscribe: Market Wire - Medical and Healthcare: Surgery and Treatments
http://img.marketwire.com/rss/mwMHSU.rss
Added By: Feedage Forager Feedage Grade A rated
Language: English
Tags:
announces  cannabis  cfn media  company  group  health  legal cannabis  marketwired sep  marketwired  media  medical  sep  today 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Market Wire - Medical and Healthcare: Surgery and Treatments

Marketwired - Surgery and Treatments



Marketwired - Surgery and Treatments



Last Build Date: Fri, 22 Sep 2017 17:21:44 EDT

Copyright: Copyright: (C) Marketwired
 



Dr. Kaveh Alizadeh Unveils a New Web Presence for His NYC-Based Plastic Surgery Practice

Fri, 22 Sep 2017 16:50:00 EDT

Potential and returning patients are invited to learn about the plastic surgery and nonsurgical options available at Cosmoplastic Surgery, as well as about Dr. Kaveh Alizadeh's global humanitarian work.




Rennova Health, Inc. Announces Reverse Stock Split

Fri, 22 Sep 2017 16:30:00 EDT

WEST PALM BEACH, FL--(Marketwired - September 22, 2017) - Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAZ) today announced that effective at 5:00 pm, Eastern Time, on October 5, 2017 (the "Effective Time"), the Company will effect a 1 for 15 reverse stock split of its outstanding common stock. The Company's common stock will open for trading on The NASDAQ Capital Market on Friday October 6, 2017, on a post-split basis.




ORHub (ORHB) Announces COO Leave of Absence

Fri, 22 Sep 2017 16:15:00 EDT

NEWPORT BEACH, CA--(Marketwired - Sep 22, 2017) - ORHub, Inc. (OTC: ORHB), a medical software company focused on delivering case-based data analytics at the speed of surgery, today announced that its Chief Operating Officer, Cyrus P. Olsen, will be taking a leave of absence, effective as of September 19.




Endonovo Therapeutics, Inc. and Kodiak Capital Group, LLC Announce Settlement and Dismissal of Lawsuit

Fri, 22 Sep 2017 13:08:34 EDT

LOS ANGELES, CA--(Marketwired - Sep 22, 2017) -  Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a developer of non-invasive electroceuticals for the treatment of vascular diseases and inflammatory conditions, and Kodiak Capital Group, LLC ("Kodiak"), a private equity firm, today announced a settlement agreement and dismissal of complaints and cross-complaints arising out of a contemplated equity investment by Kodiak in Endonovo.




The Alliance for Regenerative Medicine Submits Letter to Congress Detailing Concerns with the Senate's American Health Care Act

Fri, 22 Sep 2017 13:06:48 EDT

WASHINGTON, DC--(Marketwired - Sep 22, 2017) - The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the gene and cellular therapies and broader regenerative medicine sector, today sent a letter to U.S. Sens. Graham (R-SC), Cassidy, MD (R-LA), Heller (R-NV) and Johnson (R-WI), detailing concerns regarding the American Health Care Act (H.R. 1628).




Olive Fertility Centre Voted Best Fertility Clinic Vancouver for the Third Year in a Row

Thu, 21 Sep 2017 17:25:33 EDT

VANCOUVER, BC--(Marketwired - September 21, 2017) - Olive Fertility Centre is proud to announce that they have been voted Best Fertility Clinic in Vancouver in the Georgia Straight Best of Vancouver Awards 2017.




SANUWAVE Health to Attend Upcoming Symposium on Advanced Wound Care (SAWC)

Thu, 21 Sep 2017 16:00:00 EDT

SUWANEE, GA--(Marketwired - Sep 21, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV) today announces the Company's planned attendance at the Symposium on Advanced Wound Care/Fall (SAWC/Fall), October 20 - 22, 2017 in Las Vegas, NV. The semi-annual SAWC meeting is the premier interdisciplinary wound care program and the largest annual gathering of wound care clinicians in the United States. More than 2,000 physicians, podiatrists, nurses, therapists, researchers, and scientists are expected to attend the 2017 SAWC/Fall meeting.




Health Union Launches AtopicDermatitis.net Online Community

Thu, 21 Sep 2017 14:15:00 EDT

"Atopic Dermatitis In America" Survey Reveals Patient Embarrassment, Frustration




Marijuana Company of America Announces Update on Hemp Growing Trials in Canada

Thu, 21 Sep 2017 13:51:01 EDT

ESCONDIDO, CA--(Marketwired - Sep 21, 2017) - MARIJUANA COMPANY OF AMERICA ("MCOA" or the "Company") (OTC PINK: MCOA), in conjunction with its joint venture partner, Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC PINK: GBHPF), is pleased to provide an update on the hemp cultivation trials conducted in New Brunswick, Canada.




Eyetronic therapy: New milestone reached with 300 patients treated

Thu, 21 Sep 2017 10:00:00 EDT

Proven optic nerve stimulation can improve field of vision in patients with glaucoma and other optic neuropathies




Westchester Plastic Surgeon Discusses Connection Between Cancer and Male Breast Enlargement

Thu, 21 Sep 2017 08:01:00 EDT

Dr. Neal Goldberg reveals whether gynecomastia can lead to breast cancer in men and how to tell the difference between the two conditions




InspireMD Announces Distribution Agreement for CGuard(TM) EPS in Portugal

Thu, 21 Sep 2017 07:30:00 EDT

TEL AVIV, ISRAEL--(Marketwired - Sep 21, 2017) - InspireMD, Inc. (NYSE MKT: NSPR) (NYSE American: NSPR) (NYSE MKT: NSPR.WS) (NYSE American: NSPR.WS) ("InspireMD" or the "Company"), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it has signed an agreement with Medicinália Cormédica MC Medical Lda, a leading medical distributor in Portugal, to distribute CGuardT EPS (Embolic Prevention System). Medicinália Cormédica MC Medical Lda is a subsidiary of WerfenLife Company, one of Europe's largest distributors of medical products.




Mayo Clinic Doctor Joins Advanced Medical Isotope Corporation's (ADMD) Medical Advisory Board

Thu, 21 Sep 2017 07:22:00 EDT

RICHLAND, WA--(Marketwired - Sep 21, 2017) - Advanced Medical Isotope Corporation (OTC PINK: ADMD), a late stage radiation oncology focused medical device company strengthened its Medical Advisory Board with the recent addition of Dr. Beau Toskich from Mayo Clinic, who has been informally working with the Company's advisory board for the last six months.




SHIEC Elects 2017-2018 Board of Directors

Wed, 20 Sep 2017 10:20:51 EDT

Collaborative Expands Board with Addition of Three New Seats




SANUWAVE Announces Exhibition at Medica in Cooperation With State of Georgia; Visit us at Booth 16D10-8 in Hall 16

Wed, 20 Sep 2017 09:00:00 EDT

SUWANEE, GA--(Marketwired - Sep 20, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that the company will exhibit, in conjunction with Georgia Department of Economic Development, at MEDICA in Dusseldorf, Germany on 13 -16 November 2017. SANUWAVE cordially invites you to our section of booth 16D10-8 in Hall 16. MEDICA is the world's leading trade fair for the medical industry. SANUWAVE is using this occasion to further educate on our lead wound care product, dermaPACE® and our industry leader for the treatment of various orthopedic conditions, orthoPACE®.




CFN Media Exclusive Interview with United Cannabis: Developing Anti-Inflammatory Pharmaceuticals

Wed, 20 Sep 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Sep 20, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an exclusive interview with United Cannabis Corp.'s (OTCQB: CNAB) Chief Science Officer Dr. Brent Reynolds, PhD. In the interview, Dr. Reynolds discusses the importance of clinical development and how the company's recent acquisition of Prana Therapeutics plays into its overall strategy.




True Leaf: Crowdfunding Legal Cannabis Products Across North America -- CFN Media

Wed, 20 Sep 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Sep 20, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article examining True Leaf Medicine International Ltd. (CSE: MJ) (CNSX: MJ) (MJ.CN) (OTCQB: TRLFF) and its pending Regulation A+ public offering that is giving anyone the opportunity to invest in hemp and cannabis products that will be fully legal in both the U.S. and Canada. True Leaf's mission is to create safe, natural cannabis based products that enhance the quality of life for both people and pets. The company already has pet products in the market, and is in the final stages of Canadian approval to grow and sell legal cannabis.




ABcann Global Enters Its Growth Phase (Plus Exclusive Interview) -- CFN Media

Wed, 20 Sep 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Sep 20, 2017) -  CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an exclusive interview with ABcann Global Corporation's (TSX VENTURE: ABCN) (OTCQB: ABCCF) Aaron Keay, former CEO and current member of the Board of Directors. In the interview, Mr. Keay discusses the company's transition to new CEO Barry Fishman, as well as the opportunities ahead for the company in both Canada and internationally.




Abattis Prepares for Growth in Extracts -- CFN Media

Wed, 20 Sep 2017 08:30:00 EDT

SEATTLE, WA--(Marketwired - Sep 20, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing Abattis Bioceuticals Corp. (CSE: ATT) (ATT.CN) (CNSX: ATT) (OTCQB: ATTBF) and why its proprietary extraction technology represents an important breakthrough that shouldn't be ignored. While many licensed producers are focused on expanding capacity, the best opportunities may be those that can add value for existing licensed producers. These opportunities include those companies focused on higher value cannabis extracts.




Protext Pharma Announces South Africa's Reclassification of Cannabis as a Schedule 4 Substance

Wed, 20 Sep 2017 08:30:00 EDT

Company Provides Update on its Cannabis License Application




InMed Pharma: A Leader in Cannabinoid Biosynthesis -- CFN Media

Wed, 20 Sep 2017 08:30:00 EDT

SEATTLE, WA--(Marketwired - Sep 20, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article covering how InMed Pharmaceuticals Inc. (CSE: IN) (CNSX: IN) (IN.CN) (OTCQB: IMLFF) is leveraging biosynthesis to solve a major problem in the medical cannabis industry as it adds key ex-Eli Lilly personnel to its efforts.




HemCare Health Services Appoints Telecom Veteran Daniel G. Cullen as Chief Technology Officer

Wed, 20 Sep 2017 08:00:00 EDT

LAS VEGAS, NV--(Marketwired - Sep 20, 2017) - HemCare Health Services Inc. (OTC PINK: HCRE) is pleased to announce the appointment of Daniel G. Cullen as Chief Technology Officer. Mr. Cullen will be responsible for HemCare Health Services technology strategy and execution. In this capacity he will lead the company's engineering and software development team and spearhead the company's new technology initiatives in the application of Blockchain technology. Mr. Cullen will report directly to John Wilkes, CEO of Hemcare.




Dr. Ellen Turner, Dermatologist in Dallas, TX, To Feature "Best of 2017" Treatments in Exclusive October Showcase

Tue, 19 Sep 2017 18:30:00 EDT

As part of her efforts to continually educate patients and provide them with the most effective treatment protocols that cosmetic dermatology has to offer, dermatologist Dr. Ellen Turner is hosting "Showcase Showdown" at her Dallas practice on Oct. 26, 2017




Dr. Patrick M. Fratellone Joins Canbiola, Inc. (CANB) as Medical Advisor and Distributor

Tue, 19 Sep 2017 10:30:00 EDT

HICKSVILLE, NY--(Marketwired - Sep 19, 2017) - Canbiola, Inc. (OTC PINK: CANB) announced today that the company has added Dr. Fratellone to its Medical Advisory Board and engaged Dr. Fratellone as a distributor for Canbiola products. Dr. Fratellone is an attending physician at St. Luke's Hospital, Roosevelt Hospital, and Beth Israel Hospital, and current professor at University of Bridgeport College of Naturopathic Medicine. In addition, he bridges East Meets West at the Center of Excellence in Bridgeport CT with author Dr. Peter D'Adamo of Eat Right for Your Blood Type. Dr. Fratellone has appeared on multiple shows, and is considered an expert in his field as well a visionary. Dr. Fratellone stated, "As one of the few MDs in the US who is also a registered herbalist, I believe in traditional and time honored treatments, but also to look outside of the box; to that end CBD is certainly part of the future in my opinion with clear benefits to patients. I look forwarded to working with Canbiola, as well as educating the public on the vast benefits of CBD through blogs and speaking engagements."




FDA Grants ALRT Clearance for Insulin Dose Adjustment (IDA) Feature

Tue, 19 Sep 2017 10:02:29 EDT

IDA is designed to ensure that patients get an effective and timely insulin dose(s) based on accurate data about their specific needs




Avadim Technologies Inc. Announces Partnership With Cardinal Health, Inc.

Tue, 19 Sep 2017 09:15:00 EDT

Cardinal Health, a Global, Integrated Healthcare Services and Products Company Ranked #15 of Fortune 500 Companies, Will Now Supply Theraworx(R) Technology to its Acute Care and Long-Term Care Customers




Pivot Pharma Looks to Improve Cannabinoid Bioavailability with Topical BiPhasix(TM) Delivery System -- CFN Media

Tue, 19 Sep 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Sep 19, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article examining Pivot Pharmaceuticals Inc. (OTCQB: PVOTF) and its recent acquisition of the BiPhasixT Transdermal Drug Delivery technology for the delivery of cannabinoids.




Medovex Corporation Launches DenerveX System in Spain with Distributor Prim SA

Tue, 19 Sep 2017 08:30:00 EDT

Training and First Order Scheduled for Week of September 19th




Rennova Health Announces Big South Fork Medical Center Provided Services to Over 1,000 Patients in First Month of Operation

Tue, 19 Sep 2017 08:30:00 EDT

WEST PALM BEACH, FL--(Marketwired - September 19, 2017) - Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAZ) ("Rennova" or the "Company"), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, announces that Big South Fork Medical Center's Emergency Room has received 1,005 visits in its first month of operation and admitted 45 patients for overnight stays.




Viveve to Present at the Ladenburg Thalmann 2017 Healthcare Conference

Tue, 19 Sep 2017 08:28:00 EDT

ENGLEWOOD, CO--(Marketwired - September 19, 2017) - Viveve Medical, Inc. ("Viveve") (NASDAQ: VIVE), a medical technology company focused on women's health, today announced that Patricia Scheller, chief executive officer, will present at the 2017 Ladenburg Thalmann Healthcare Conference, on Tuesday, September 26th at 9:30AM ET in New York City. Ms. Scheller will provide an update of the Company's global development and commercialization of the GENEVEVET Treatment and InControl Products by Viveve.




Cannabis Science "Nanoparticle Drones to Target Lung Cancer with Radiosensitizers and Cannabinoids" Full Publication Released Today In Frontiers In Oncology

Tue, 19 Sep 2017 08:18:05 EDT

IRVINE, CA--(Marketwired - Sep 19, 2017) -  Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces the full publication of initial research results on using nanoparticle drones to target lung cancer with radiosensitizers and cannabinoids in the world-renowned cancer research journal, Frontiers in Oncology, released today.




Graybug Vision Initiates Phase 1/2 Trial of GB-102 for Wet Age-related Macular Degeneration

Tue, 19 Sep 2017 08:00:00 EDT

Novel Injectable Formulation for Potential Twice Per Year Treatment




MetLife Hong Kong Expands Coverage for People with Diabetes and Introduces Insurtech Solution

Tue, 19 Sep 2017 05:21:20 EDT

HONG KONG, CHINA--(Marketwired - Sep 19, 2017) - MetLife Hong Kong* announced today that it has extended the scope of its "MetLife Health-is-Wealth Medical Plan" to include people living with diabetes, and offered its customers insurtech solutions for proactive health management. For the 1 in 10 people in Hong Kong living with diabetes, finding insurance cover that provides comprehensive coverage has historically been a challenge. MetLife Hong Kong's inclusive action will make medical protection more accessible to this group of people.




Industry Leader, Darren Cherry, Leads Advantis Corp. Into the Future

Tue, 19 Sep 2017 01:53:03 EDT

NEWPORT BEACH, CA--(Marketwired - Sep 19, 2017) - ADVANTIS CORPORATION (OTC PINK: ADVT) announced that it has agreed with leading wholesale, marketing, and logistics expert, Darren Cherry, to take the helm as its new CEO.




Medigus Announces Second Quarter 2017 Financial Results

Mon, 18 Sep 2017 16:05:00 EDT

OMER, ISRAEL--(Marketwired - Sep 18, 2017) - Medigus Ltd. (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and direct visualization technology, today announced financial results for the second quarter ended June 30, 2017.




Pressure BioSciences' Next-Generation Barocycler 2320EXTREME Named a Finalist in the Prestigious 2017 R&D 100 Awards

Mon, 18 Sep 2017 09:46:37 EDT

Considered Among the Most Prestigious Recognitions of Invention and Innovation Worldwide, the R&D 100 Awards Identify the Top 100 Revolutionary Technologies of the Past Year




GeoVax Provides Update on its Zika Vaccine Development

Mon, 18 Sep 2017 09:00:00 EDT

Presentation Made During 11th Vaccine Congress in San Diego




MediXall Group, Inc. Creates Multiple Revenue Streams in September 2017

Mon, 18 Sep 2017 08:00:00 EDT

FT. LAUDERDALE, FL--(Marketwired - Sep 18, 2017) - MediXall Group, Inc. (OTCQB: MDXL) announced today that three additional revenue streams are in place and operational, creating additional value in the company. The mission of the MediXall Group is to revolutionize the medical industry by improving communication; providing better technology and support services; and enabling more efficient, cost-effective healthcare for the consumer. Prior to the planned October launch of the MediXaid Healthcare Platform, a subsidiary of MediXall Group with over 3,500 practitioners and diagnostic centers participating, to date, the company has signed agreements with strategic partners, SafeRide and PWeR®, who offer strong solutions to help network practitioners grow their businesses.




Titan Medical and Florida Hospital Nicholson Center Announce the World's First Installation of Sport Surgical System

Mon, 18 Sep 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - September 18, 2017) - Titan Medical Inc. ("Titan" or the "Company") (TSX: TMD) (OTCQB: TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (MIS), and Florida Hospital Nicholson Center announce the installation of Titan Medical's SPORT Surgical System at the hospital's training facility in Celebration, Florida. This is the first installation in the world for pre-clinical feasibility and validation studies of the SPORT Surgical System, a single port robotic system.